Hypoxic-ischemia (HI) is a major cause of acquired visual impairment in children from developed countries. Previous studies have shown that systemic administration 7,8-dihydroxyavone (DHF), selective tropomyosin receptor kinase B (TrkB) agonist, provides long-term neuroprotection against HI injury an immature retina. However, the target genes and mechanisms neuroprotective effects TrkB signalin...